Calamos Advisors LLC Iradimed Corp Transaction History

Calamos Advisors LLC

$14.5 Billion
Q1 2024

A detailed history of Calamos Advisors LLC transactions in Iradimed Corp stock. As of the latest transaction made, Calamos Advisors LLC holds 5,073 shares of IRMD stock, worth $222,907. This represents 0.0% of its overall portfolio holdings.

Number of Shares

5,073

Previous 35,202 85.59%

Holding current value

$222,907

Previous $1.67 Million 86.65%

% of portfolio

0.0%

Previous 0.01%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	SELL	$41.17 - $47.29 $1.24 Million - $1.42 Million	-30,129 Reduced 85.59%	5,073 $223,000
Q4 2023 Jan 31, 2024	SELL	$37.31 - $47.47 $27,422 - $34,890	-735 Reduced 2.05%	35,202 $1.67 Million
Q3 2023 Oct 25, 2023	BUY	$43.28 - $50.3 $129,840 - $150,900	3,000 Added 9.11%	35,937 $1.59 Million
Q2 2023 Jul 28, 2023	BUY	$38.88 - $50.61 $67,184 - $87,454	1,728 Added 5.54%	32,937 $1.57 Million
Q1 2023 May 03, 2023	BUY	$28.48 - $42.14 $528,360 - $781,781	18,552 Added 146.58%	31,209 $1.23 Million

Q4 2022 Jan 25, 2023	SELL	$26.9 - $30.58 $1.62 Million - $1.84 Million	-60,105 Reduced 82.6%	12,657 $0
Q3 2022 Oct 24, 2022	SELL	$29.42 - $42.25 $226,681 - $325,536	-7,705 Reduced 9.58%	72,762 $2.19 Million
Q2 2022 Aug 01, 2022	SELL	$30.15 - $45.79 $214,034 - $325,063	-7,099 Reduced 8.11%	80,467 $2.73 Million
Q1 2022 May 03, 2022	BUY	$36.01 - $53.14 $641,770 - $947,061	17,822 Added 25.55%	87,566 $3.93 Million
Q4 2021 Feb 01, 2022	BUY	$32.35 - $48.27 $2.26 Million - $3.37 Million	69,744 New	69,744 $3.22 Million
Q1 2019 Apr 12, 2019	SELL	$23.58 - $28.43 $276,829 - $333,768	-11,740 Closed	0 $0
Q3 2018 Oct 22, 2018	BUY	$20.6 - $37.15 $241,844 - $436,141	11,740 New	11,740 $436,000

Others Institutions Holding IRMD

# of Institutions

127

Shares Held

6.75M

Call Options Held

7.7K

Put Options Held

View Full List

About IRADIMED CORP

Ticker IRMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 12,565,100
Market Cap $552M
Description
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible pati...

More about IRMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Calamos Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Calamos Advisors LLC with notifications on news.

Account

Calamos Advisors LLC Iradimed Corp Transaction History